Opdivo 40
Drug Category |
|
Medicinal form |
Vials |
Active ingredient |
|
Concentration |
40mg |
Manufacturer |
|
Price |
5796 EGP |
Uses
Indicated in the treatment of malignant lymphomas, acute lymphoplastic leukemia, hodgkins disease, astrocyroma, urinary blader carcinoma, and neuroblastoma. Dosage:monothera y 300 mg/mm for 3-5 days, repeted every 3 weeks.
Note: The information provided about this drug does not substitute for consulting a doctor.
Direct Access to Pharmacy Through Innovative Portal
Empower your health journey with Direct Access to Pharmacy Through Innovative Portal - Your gateway to seamless and efficient healthcare solutions at your fingertips
See list pharmacies